🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ASCO23 Emily Liang presenting her work on CD19 CAR-T in CLL. She is a rockstar!

Thanks to all who collaborated on this project! Our ASCO poster on CAR-T outcomes among R/R patients with Burkitts highlights a need for new strategies to treat this rare disease.

My colleague Hiba Khan MD MPH gave a meaningful talk ASCO this morning, highlighting a higher risk for mortality in patients who experience adverse financial events. It's also interesting to see the risk of death among common cancer types.

Breast cancer - most common cancer in sub-Saharan Africa - and BBI’s Dr. Manoj Menon @FredHutch at ASCO meeting sharing insights on molecular testing on breast cancer tumors from Uganda Cancer Institute patients. conferences.asco.org/am/program?cmp…

I am, of course, biased, but I loved our first "Seattle Cellular Therapy Summit." Enjoyed working with Krish Patel ' Binay Shah, MD, MHA and the Binaytara Foundation staff. Thanks to our great speakers, attendees, and supporters. Save the date for our next summit on 8/16-17/24!

Thank you to ASH and all of our collaborators who made this project possible! So happy to see our results published in Blood Advances!

The U.S. FDA approves Bristol Myers Squibb lisocabtagene maraleucel for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Kudos to all investigators and sites involved! news.bms.com/news/details/2… Mazyar Shadman, MD MPH